GVR Report cover Digital Patient Monitoring Devices Market Size, Share & Trends Report

Digital Patient Monitoring Devices Market Size, Share & Trends Analysis Report By Type (Wireless Sensor Technology, mHealth, Telehealth, Wearable Devices, Remote Patient Monitoring), By Product, By Region, And Segment Forecasts, 2021 - 2028

  • Report ID: 978-1-68038-767-4
  • Number of Pages: 141
  • Format: Electronic (PDF)
  • Historical Range: 2016 - 2019
  • Industry: Healthcare

Report Overview

The global digital patient monitoring devices market size was estimated at USD 62.6 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 23.5% from 2021 to 2028. Rising demand for continuous monitoring devices and increasing prevalence of chronic diseases such as diabetes, hypertension, cardiovascular diseases, and others are factors propelling the growth of the market.

U.S. digital patient monitoring devices market size, by type, 2016 - 2028 (USD Billion)

In recent years, the adoption of sensor-based wearable devices such as continuous glucose monitors, ECG, and others is increasing among patients as well as healthcare providers. These devices can track the patient’s vital signs on a real-time basis which can then be transmitted to their doctors electronically and can also be integrated with the EHR. This allows the providers to continuously monitor the patient eliminating the need for frequent hospital visits. The rising demand for wearable devices has encouraged key players to carry intensive research and launch innovative products in the market for digital patient monitoring devices. For example, in March 2020, Somatix, Inc. announced the launch of an AI-powered continuous remote patient monitoring system. The introduction of similar innovative products is anticipated to augment the digital patient monitoring device market growth.

Incorporating digital patient monitoring systems can help in significant cost savings, thereby reducing the overall healthcare cost. Many countries across the globe are dealing with the economic burden of chronic diseases. According to the Centers for Disease Control and Prevention, heart disease and stroke costs around USD 214 billion to the U.S. healthcare system every year. With the use of digital patient monitoring systems, people at risk can be monitored remotely, thus preventing hospitalization and reducing healthcare costs. This is likely to favor the growth of the market for digital patient monitoring devices in the coming years.

COVID19 digital patient monitoring devices market impact: 32% growth from 2019 to 2020

Pandemic Impact

Post COVID Outlook

The digital patient monitoring devices market witnessed an increment of over 32% from 2019 to 2020, as per the earlier projection the market was expected to be nearly USD 60 billion in 2020

In 2021 the market will continue to witness growth as the risk of infection is pertains.

The emergence of the pandemic increased demand for vital signs monitors, such as respiration rate, pulse rate, and temperature can serve as an effective infection-detection system for people infected with the virus.

The demand for mhealth and wearable devices is anticipated to grow as the pandemic greatly contributed to an increase in the general population’s desire to maintain fitness


The COVID-19 pandemic brought a digital revolution in the healthcare industry by increasing the demand for wearable devices, mHealth apps, and telehealth by multiple folds. To control the spread of infection and patient volumes, hospitals were forced to shut down their OPDs and shift to digital health. According to a survey conducted by VivaLNK, a connected healthcare solution provider, 55% of the respondents were using or planning to use Remote Patient Monitoring (RPM) for COVID-19 patients.

The government of many countries has started embracing digital health tools after realizing their potential. For instance, in April 2020, the Federal Communications Commission started a COVID-19 relief program which provided USD 200 million to equip hospitals with telehealth technology. This has opened new opportunities for the market players and start-up companies to develop innovative solutions. For example, in May 2020, VitalConnect, Inc. received Emergency Use Authorization from the USFDA for its cardiac monitoring device VitalPatch for use in COVID-19 patients. 

Type Insights

The wearable devices segment dominated the market for digital patient monitoring devices and accounted for the largest revenue share of 30.4% in 2020. Increasing adoption of connected devices and rising end-user preference for sophisticated gadgets are factors attributable to the prominent share of the segment. The mHealth segment is projected to witness substantial growth during the forecast period. Rising internet penetration and the growing number of smartphone users are expected to drive the growth of the segment. Furthermore, the increasing number of startups entering the market for digital patient monitoring devices is fueling segment growth. For instance, in August 2020, Undermyfork, an app for tracking diabetes received funding of USD 0.4 million. The app is about to be launched in the U.S.

Product Insights

Based on product, the diagnostic monitoring devices segment dominated the market for digital patient monitoring devices and accounted for the largest revenue share of 62.5% in 2020. The increasing prevalence of diseases such as diabetes, obesity, cancer, and others and the rising geriatric population are propelling the growth of the segment. According to the International Diabetes Federation, around 463 million people are living with diabetes in 2019 and the number is projected to reach 700 million by 2045. This is likely to favor the growth of the segment.

Apart from this, increasing demand for respiratory monitors such as pulse oximeters especially among COVID-19 patients is poised to surge the therapeutic monitoring devices segment growth. Furthermore, a growing number of strategic partnerships among key manufacturers are expected to positively impact the segment. For instance, in June 2020, Abbott partnered with Tandem Diabetes Care. Under this partnership, Abbott combined its Continuous Glucose Monitoring (CGM) technology with Tandem Diabetes Care’s insulin delivery systems.

Regional Insights

North America dominated the market for digital patient monitoring devices and accounted for the largest revenue share of 41.3% in 2020. Strong government support to reduce the healthcare cost burden, technological advancements, and the launch of new products are responsible for the dominant share of the region. In July 2020, Medtronic announced 510(k) clearance from U.S. FDA approval for LINQ II insertable cardiac monitor. This coupled with rising cases of heart diseases is expected to drive the market for digital patient monitoring devices in North America.

Global digital patient monitoring devices market share, by region, 2020 (%)

In Europe, the market for digital patient monitoring devices is likely to propel owing to the favoring government policies for mHealth and telehealth. In January 2019, NHS announced its long-term plan to make telehealth and mHealth a standard of care by 2022-23. This is expected to favor market adoption in Europe. Asia Pacific is anticipated to witness remarkable growth owing to the highest number of smartphone users in China and India and deeper internet penetration. According to India Cellular and Electronics Association, smartphone users in India are projected to increase from 500 million in 2019 to 820 million by 2022. This is likely to favor the market for digital patient monitoring devices in Asia Pacific.

Key Companies & Market Share Insights

Abbott emerged as one of the market leaders due to its strong product portfolio, update of current products as per patient needs, and wide geographical foothold. Apart from this, Koninklijke Philips N.V. held a prominent position in the market owing to the company’s strong focus on R&D. In June 2020, Koninklijke Philips N.V. launched Avalon CL Fetal and Maternal Patch and Pod, an obstetrics monitoring solution, in the U.S. Some of the prominent players in the digital patient monitoring devices market include:

  • GE Healthcare

  • AT&T


  • Abbott

  • Koninklijke Philips N.V. AB

  • Hill-Rom Services Inc.

  • Medtronic

  • Omron Healthcare, Inc.

  • FitBit, Inc.

  • Garmin Ltd.

  • VitalConnect

  • ResMed

  • Siren

Digital Patient Monitoring Devices Market Report Scope

Report Attribute


Market size value in 2021

USD 82.4 billion

Revenue forecast in 2028

USD 446.0 billion

Growth Rate

CAGR of 23.5% from 2021 to 2028

Base year for estimation


Historical data

2016 - 2019

Forecast period

2021 - 2028

Quantitative units

Revenue in USD Million and CAGR from 2021 to 2028

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Type, product, region

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country scope

U.S.; Canada; France; Germany; Italy; Spain; U.K.; Japan; China; India; Brazil; Mexico; South Africa; Saudi Arabia

Key companies profiled

GE Healthcare; AT&T; ATHENAHEALTH, INC.; Abbott; Koninklijke Philips N.V. AB; Hill-Rom Services Inc.; Medtronic; Omron Healthcare, Inc.; FitBit, Inc.; Garmin Ltd.; VitalConnect; ResMed; Siren

Customization scope

Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional and segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global digital patient monitoring devices market report on the basis of type, product, and region:

  • Type Outlook (Revenue, USD Million, 2016 - 2028)

    • Wireless Sensor Technology

    • mHealth

    • Telehealth

    • Wearable Devices

    • Remote Patient Monitoring

      • Hospital Inpatient

      • Ambulatory Patient

      • Smart Home healthcare

  • Product Outlook (Revenue, USD Million, 2016 - 2028)

    • Diagnostic Monitoring Devices

      • Vital Sign Monitors

      • Sleep Monitors

      • Fetal Monitors

      • Neuromonitors

      • Other Monitors

    • Therapeutic Monitoring Devices

      • Insulin Monitors

      • Respiratory Monitors

      • Other Monitors

  • Regional Outlook (Revenue, USD Million, 2016 - 2028)

    • North America

      • U.S.

      • Canada

    • Europe

      • France

      • Germany

      • Italy

      • Spain

      • U.K.

    • Asia Pacific

      • Japan

      • China

      • India

    • Latin America

      • Brazil

      • Mexico

    • Middle East & Africa (MEA)

      • South Africa

      • Saudi Arabia

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon